{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:35:51Z","timestamp":1788568551918,"version":"build-2803163510"},"reference-count":44,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>von Willebrand disease (VWD) disproportionately affects women because of the potential for heavy menstrual bleeding (HMB), delivery complications, and postpartum hemorrhage (PPH). To systematically synthesize the evidence regarding first-line management of HMB, treatment of women requiring or desiring neuraxial analgesia, and management of PPH. We searched Medline and EMBASE through October 2019 for randomized trials, comparative observational studies, and case series comparing the effects of desmopressin, hormonal therapy, and tranexamic acid (TxA) on HMB; comparing different von Willebrand factor (VWF) levels in women with VWD who were undergoing labor and receiving neuraxial anesthesia; and measuring the effects of TxA on PPH. We conducted duplicate study selection, data abstraction, and appraisal of risk of bias. Whenever possible, we conducted meta-analyses. We assessed the quality of the evidence using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. We included 1 randomized trial, 3 comparative observational studies, and 10 case series. Moderate-certainty evidence showed that desmopressin resulted in a smaller reduction of menstrual blood loss (difference in mean change from baseline, 41.6 [95% confidence interval, 16.6-63.6] points in a pictorial blood assessment chart score) as compared with TxA. There was very-low-certainty evidence about how first-line treatments compare against each other, the effects of different VWF levels in women receiving neuraxial anesthesia, and the effects of postpartum administration of TxA. Most of the evidence relevant to the gynecologic and obstetric management of women with VWD addressed by most guidelines is very low quality. Future studies that address research priorities will be key when updating such guidelines.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005589","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T20:54:35Z","timestamp":1634849675000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9900","authenticated-orcid":false,"given":"Romina","family":"Brignardello-Petersen","sequence":"first","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"El Alayli","sequence":"additional","affiliation":[{"name":"Outcomes and Implementation Research Unit, Department of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedaa","family":"Husainat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St. Mary\u2019s Hospital, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-4561","authenticated-orcid":false,"given":"Mohamad A.","family":"Kalot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, State University of New York at Buffalo, Buffalo, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaneela","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Department of Pediatrics, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Aljabirii","sequence":"additional","affiliation":[{"name":"Lincoln Medical and Mental Health Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7084-7053","authenticated-orcid":false,"given":"Alec","family":"Britt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alturkmani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine University of Arkansas for Medical Sciences, Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"El-Khechen","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Motaghi","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-3735","authenticated-orcid":false,"given":"John","family":"Roller","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-1006","authenticated-orcid":false,"given":"Rezan","family":"Abdul-Kadir","sequence":"additional","affiliation":[{"name":"The Royal Free National Health Service Foundation (NHS) Hospital and Institute for Women\u2019s Health, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Couper","sequence":"additional","affiliation":[{"name":"Maylands, WA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-8313","authenticated-orcid":false,"given":"Peter","family":"Kouides","sequence":"additional","affiliation":[{"name":"Mary M. Gooley Hemophilia Treatment Center, University of Rochester, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-4216","authenticated-orcid":false,"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[{"name":"Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland;"},{"name":"National Coagulation Centre, St. James\u2019 Hospital, Dublin, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-0675","authenticated-orcid":false,"given":"Margareth C.","family":"Ozelo","sequence":"additional","affiliation":[{"name":"Hemocentro UNICAMP, University of Campinas, Campinas, Sao Paulo, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Weyand","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-9014","authenticated-orcid":false,"given":"Paula D.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-7826","authenticated-orcid":false,"given":"Nathan T.","family":"Connell","sequence":"additional","affiliation":[{"name":"Hematology Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica H.","family":"Flood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and"},{"name":"Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-0875","authenticated-orcid":false,"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Outcomes and Implementation Research Unit, Department of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"2","key":"2022011016242090400_B1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia."},{"issue":"7","key":"2022011016242090400_B2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"BJOG."},{"issue":"7","key":"2022011016242090400_B3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3324\/haematol.2019.225656","article-title":"Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort","volume":"105","author":"Zia","year":"2020","journal-title":"Haematologica."},{"issue":"2","key":"2022011016242090400_B4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejogrb.2011.04.025","article-title":"Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel","volume":"158","author":"James","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"5","key":"2022011016242090400_B5","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3892\/etm.2016.3144","article-title":"Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand\u2019s disease","volume":"11","author":"Govorov","year":"2016","journal-title":"Exp Ther Med."},{"issue":"5","key":"2022011016242090400_B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2516.1999.00342.x","article-title":"von Willebrand disease and bleeding in women","volume":"5","author":"Ragni","year":"1999","journal-title":"Haemophilia."},{"issue":"14","key":"2022011016242090400_B7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv."},{"key":"2022011016242090400_B8","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: a systematic review","volume":"39","author":"Punt","year":"2020","journal-title":"Blood Rev."},{"issue":"3","key":"2022011016242090400_B9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand\u2019s disease or factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol."},{"issue":"1","key":"2022011016242090400_B10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia."},{"issue":"6","key":"2022011016242090400_B11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2516.2000.00447.x","article-title":"Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey","volume":"6","author":"Kouides","year":"2000","journal-title":"Haemophilia."},{"issue":"6","key":"2022011016242090400_B12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J\u00a0Thromb Haemost."},{"issue":"12","key":"2022011016242090400_B13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00101-011-1930-z","article-title":"R\u00fcckenmarknahe Regionalan\u00e4sthesie bei Patienten mit h\u00e4morrhagischen Diathesen: Entscheidungen am Rande des Evidenzminimums? [Spinal and epidural anesthesia in patients with hemorrhagic diathesis: decisions on the brink of minimum evidence? In German]","volume":"60","author":"Englbrecht","year":"2011","journal-title":"Anaesthesist."},{"issue":"3","key":"2022011016242090400_B14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/AOG.0b013e3181b191ea","article-title":"Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines","volume":"114","author":"James","year":"2009","journal-title":"Obstet Gynecol."},{"issue":"5","key":"2022011016242090400_B15","first-page":"391","article-title":"A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF\/FVIII concentrates in severe inherited von Willebrand disease","volume":"17","author":"Peyvandi","year":"2019","journal-title":"Blood Transfus."},{"issue":"5","key":"2022011016242090400_B16","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1111\/hae.13051","article-title":"Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial","volume":"22","author":"Eghbali","year":"2016","journal-title":"Haemophilia."},{"issue":"3","key":"2022011016242090400_B17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"Leissinger","year":"2001","journal-title":"Haemophilia."},{"issue":"1","key":"2022011016242090400_B18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.13881","article-title":"An international survey to inform priorities for new guidelines on von Willebrand disease","volume":"26","author":"Kalot","year":"2020","journal-title":"Haemophilia."},{"issue":"1","key":"2022011016242090400_B19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"2022011016242090400_B20","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/bloodadvances.2020001768","article-title":"Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences","volume":"4","author":"Wiercioch","year":"2020","journal-title":"Blood Adv."},{"key":"2022011016242090400_B21","author":"R Manager","year":"2014"},{"key":"2022011016242090400_B22","year":"2021"},{"issue":"4","key":"2022011016242090400_B23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"12","key":"2022011016242090400_B24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision [published correction appears in J Clin Epidemiol. 2021;137:265]","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"2022011016242090400_B25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol."},{"issue":"7","key":"2022011016242090400_B26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.mph.0000173175.95152.95","article-title":"Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study","volume":"27","author":"Amesse","year":"2005","journal-title":"J Pediatr Hematol Oncol."},{"issue":"6","key":"2022011016242090400_B27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jpag.2015.03.001","article-title":"Menstrual patterns and treatment of heavy menstrual bleeding in adolescents with bleeding disorders","volume":"28","author":"Dowlut-McElroy","year":"2015","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"6","key":"2022011016242090400_B28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hae.12184","article-title":"Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders","volume":"19","author":"Rimmer","year":"2013","journal-title":"Haemophilia."},{"issue":"4","key":"2022011016242090400_B29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpag.2016.04.001","article-title":"Levonorgestrel-releasing intrauterine device use in female adolescents with heavy menstrual bleeding and bleeding disorders: single institution review","volume":"30","author":"Adeyemi-Fowode","year":"2017","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"3","key":"2022011016242090400_B30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception."},{"issue":"12","key":"2022011016242090400_B31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG."},{"issue":"3","key":"2022011016242090400_B32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2007.07.1315","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders","volume":"90","author":"Lukes","year":"2008","journal-title":"Fertil Steril."},{"issue":"8","key":"2022011016242090400_B33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol."},{"key":"2022011016242090400_B34","first-page":"S155","article-title":"A retrospective, single-centre study of central neuraxial blockade in haemophilia carrier parturients [abstract]","volume":"186","author":"Duggan","year":"2017","journal-title":"Ir J\u00a0Med Sci."},{"issue":"7","key":"2022011016242090400_B35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1471-0528.1997.tb12024.x","article-title":"The obstetric experience of carriers of haemophilia","volume":"104","author":"Kadir","year":"1997","journal-title":"Br J Obstet Gynaecol."},{"issue":"6","key":"2022011016242090400_B36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1160\/TH08-10-0694","article-title":"Obstetric analgesia and anaesthesia in women with inherited bleeding disorders","volume":"101","author":"Chi","year":"2009","journal-title":"Thromb Haemost."},{"issue":"1","key":"2022011016242090400_B37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2516.2007.01561.x","article-title":"Pregnancy in carriers of haemophilia","volume":"14","author":"Chi","year":"2008","journal-title":"Haemophilia."},{"issue":"10","key":"2022011016242090400_B38","doi-asserted-by":"crossref","first-page":"e0164683","DOI":"10.1371\/journal.pone.0164683","article-title":"Postpartum hemorrhage in women with von Willebrand disease - a retrospective observational study. [published correction appears in PLoS One. 2017;12(2):e0172185]","volume":"11","author":"Govorov","year":"2016","journal-title":"PLoS One."},{"issue":"6","key":"2022011016242090400_B39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","article-title":"Obstetric bleeding among women with inherited bleeding disorders: a retrospective study","volume":"22","author":"Hawke","year":"2016","journal-title":"Haemophilia."},{"key":"2022011016242090400_B40","article-title":"Surgical management of patients with von Willebrand Disease: summary of two systematic reviews of the literature [published online ahead of print 15 October 2021]","volume-title":"Blood.","author":"Brignardello-Petersen","year":"2021"},{"key":"2022011016242090400_B41","article-title":"Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand Disease: a systematic literature review","author":"Brignardello-Petersen","year":"2021"},{"key":"2022011016242090400_B42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bpobgyn.2017.01.001","article-title":"The current status of hormonal therapies for heavy menstrual bleeding","volume":"40","author":"Heikinheimo","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"2022011016242090400_B43","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.12659\/MSM.892126","article-title":"Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis","volume":"20","author":"Qiu","year":"2014","journal-title":"Med Sci Monit."},{"key":"2022011016242090400_B44","article-title":"Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates","volume-title":"Cochrane Methods.","author":"Higgins","year":"2020"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/228\/1858143\/advancesadv2021005589c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/228\/1858143\/advancesadv2021005589c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T14:23:23Z","timestamp":1699712603000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/1\/228\/477423\/Gynecologic-and-obstetric-management-of-women-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005589","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}